Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20201212049688N1Phase 2Completed
Phase 2, randomised trial in postoperative pain comparing Dexmedetomidine + ropivacaine with Sufentanil + ropivacaine (2 arms). Primary endpoints: Time of onset of analgesia and Duration of analgesia. Started Apr 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20201212049688N1.